PT96229B - Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico - Google Patents

Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico Download PDF

Info

Publication number
PT96229B
PT96229B PT96229A PT9622990A PT96229B PT 96229 B PT96229 B PT 96229B PT 96229 A PT96229 A PT 96229A PT 9622990 A PT9622990 A PT 9622990A PT 96229 B PT96229 B PT 96229B
Authority
PT
Portugal
Prior art keywords
weight
naproxen
binder
tablets
paste
Prior art date
Application number
PT96229A
Other languages
English (en)
Portuguese (pt)
Other versions
PT96229A (pt
Inventor
Roy Kuramoto
Zakauddin Tanwir Chowhan
Randal Owen Pendleton
Hafez Hafezzadeh
Original Assignee
Syntex Pharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Pharma Int filed Critical Syntex Pharma Int
Publication of PT96229A publication Critical patent/PT96229A/pt
Publication of PT96229B publication Critical patent/PT96229B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT96229A 1989-12-22 1990-12-18 Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico PT96229B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45510989A 1989-12-22 1989-12-22

Publications (2)

Publication Number Publication Date
PT96229A PT96229A (pt) 1991-09-30
PT96229B true PT96229B (pt) 1998-06-30

Family

ID=23807439

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96229A PT96229B (pt) 1989-12-22 1990-12-18 Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico

Country Status (16)

Country Link
EP (1) EP0436373B1 (de)
JP (1) JPH05320045A (de)
KR (1) KR910011241A (de)
AT (1) ATE110267T1 (de)
AU (1) AU640725B2 (de)
CA (1) CA2032956A1 (de)
DE (1) DE69011836T2 (de)
ES (1) ES2063296T3 (de)
FI (1) FI906372A (de)
HU (1) HUT59594A (de)
IE (1) IE904666A1 (de)
IL (1) IL96749A0 (de)
NO (1) NO905557L (de)
NZ (1) NZ236631A (de)
PT (1) PT96229B (de)
ZA (1) ZA9010353B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534551A (en) * 1992-04-15 1996-07-09 Hoechst Marion Roussel, Inc. Aminoguanidine spray drying process
WO1998024410A2 (en) * 1996-12-03 1998-06-11 Schering-Plough Kabushiki Kaisha Controlled release matrix tablet and method for its preparation
MXPA04000618A (es) * 2001-07-30 2005-06-17 Dsm Ip Assets Bv Composicion para galato epigalocatequina.
CA2472028C (en) 2002-02-01 2010-03-30 Pfizer Products Inc. Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
UY28583A1 (es) * 2003-10-30 2005-05-31 Roche Consumer Health Ag Forma de presentación del naproxeno sodico
JP2008222567A (ja) * 2007-03-08 2008-09-25 Iwate Univ 微粒子の製造方法
TW201113266A (en) * 2009-09-02 2011-04-16 Ziopharm Oncology Inc Pharmaceutical formulations for indibulin
IE20100799A1 (en) * 2010-12-22 2012-08-01 Eurand Pharmaceuticals Ltd Pharmaceutical composites of poorly water soluble drugs and polymers
WO2017010487A1 (ja) * 2015-07-13 2017-01-19 協和発酵バイオ株式会社 アルギニンを高含有する錠剤
JP6619644B2 (ja) * 2015-12-22 2019-12-11 アサヒグループ食品株式会社 錠剤の製造方法、及び錠剤原料用顆粒の製造方法
JP7163015B2 (ja) * 2016-10-31 2022-10-31 エスエス製薬株式会社 経口固形組成物
MX2022002356A (es) * 2019-08-26 2022-04-06 Dsm Ip Assets Bv Forma de dosificacion oral solida que comprende naproxeno y vitamina b12.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
DE3883098T2 (de) * 1987-07-08 1993-12-02 American Home Prod Sprühgetrocknete Ibuprofen-Zusammensetzungen.
IT1226549B (it) * 1988-07-12 1991-01-24 Resa Farma Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.

Also Published As

Publication number Publication date
IL96749A0 (en) 1991-09-16
NO905557L (no) 1991-06-24
FI906372A (fi) 1991-06-23
NO905557D0 (no) 1990-12-21
AU640725B2 (en) 1993-09-02
ZA9010353B (en) 1992-08-26
FI906372A0 (fi) 1990-12-21
EP0436373B1 (de) 1994-08-24
IE904666A1 (en) 1991-07-17
EP0436373A1 (de) 1991-07-10
PT96229A (pt) 1991-09-30
KR910011241A (ko) 1991-08-07
DE69011836D1 (de) 1994-09-29
DE69011836T2 (de) 1995-03-09
CA2032956A1 (en) 1991-06-23
ATE110267T1 (de) 1994-09-15
NZ236631A (en) 1993-03-26
ES2063296T3 (es) 1995-01-01
JPH05320045A (ja) 1993-12-03
HU908395D0 (en) 1991-07-29
AU6837590A (en) 1991-06-27
HUT59594A (en) 1992-06-29

Similar Documents

Publication Publication Date Title
JP2021178871A (ja) エンザルタミドの製剤
JP3728321B2 (ja) 圧縮性を改良した医薬品賦形剤
KR100332337B1 (ko) 압축성이우수한약부형제
CA2342309C (en) New solid dose form of nanoparticulate naproxen
JP4865989B2 (ja) 改良された噴霧乾燥装置を使用する均質な噴霧乾燥された固体の非晶質薬物分散物を製造する方法
AU2005256321B2 (en) Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention
PT96229B (pt) Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico
US10493161B2 (en) Solution for spray drying comprising hypromellose acetate succinate and method for producing solid dispersion
BRPI0620185A2 (pt) formulaÇço farmacÊutica, tabletes, e, processo para a preparaÇço de uma formulaÇço farmacÊutica
BRPI0714586A2 (pt) formulaÇço farmacÊutica de liberaÇço prolongada de metropolol e processo para a sua preparaÇço
PT2167046E (pt) Composição farmacêutica sólida que contém benzazepinas e seu processo de fabrico
ITMI991402A1 (it) Composti amorfi e relative composizioni farmaceutiche
KR101661256B1 (ko) 락토스 및 셀룰로스 주성분의 타정용 보조제
MXPA02007076A (es) Preparacion de ingrediente activo de ibuprofeno.
US5358717A (en) Directly-compressible naproxen or naproxen sodium compositions
JP4293572B2 (ja) ロキソプロフェン・ナトリウム含有錠剤
KR100267525B1 (ko) 시타라빈 옥포스페이트 경질 캡슐제
EP1103258A1 (de) Feste zubereitungen die wenig lösliche nsaids enthalten
US20030153623A1 (en) Solid preparation containing sparingly soluble NSAIDs
WO2017209216A1 (ja) 難溶性薬物の微粒子を含有する医薬組成物の製造方法
BR112019010706A2 (pt) comprimido compósito oral, e método de preparação do comprimido compósito oral
JP4591742B2 (ja) ジオクチルソジウムスルホサクシネート配合製剤およびその製造方法
KR100464210B1 (ko) 세푸록심 악세틸 함유 약제학적 조성물 및 그의 제조방법
WO2024030098A1 (en) A tablet of tolvaptan and at least one binder processed with spray granulation
TR2022012261A2 (tr) Sprey granülasyon yöntemi̇yle hazirlanmiş tolvaptan ve en az bi̇r bağlayici i̇çeren bi̇r tablet

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910506

FG3A Patent granted, date of granting

Effective date: 19980313

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19990930